Your browser doesn't support javascript.
loading
Super enhancers define regulatory subtypes and cell identity in neuroblastoma.
Gartlgruber, Moritz; Sharma, Ashwini Kumar; Quintero, Andrés; Dreidax, Daniel; Jansky, Selina; Park, Young-Gyu; Kreth, Sina; Meder, Johanna; Doncevic, Daria; Saary, Paul; Toprak, Umut H; Ishaque, Naveed; Afanasyeva, Elena; Wecht, Elisa; Koster, Jan; Versteeg, Rogier; Grünewald, Thomas G P; Jones, David T W; Pfister, Stefan M; Henrich, Kai-Oliver; van Nes, Johan; Herrmann, Carl; Westermann, Frank.
Afiliação
  • Gartlgruber M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Sharma AK; Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany.
  • Quintero A; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Dreidax D; Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany.
  • Jansky S; Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany.
  • Park YG; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Kreth S; Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany.
  • Meder J; Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany.
  • Doncevic D; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Saary P; Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany.
  • Toprak UH; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Ishaque N; Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany.
  • Afanasyeva E; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Wecht E; Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany.
  • Koster J; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Versteeg R; Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany.
  • Grünewald TGP; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Jones DTW; Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany.
  • Pfister SM; Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany.
  • Henrich KO; Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany.
  • van Nes J; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Herrmann C; Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany.
  • Westermann F; Center for Digital Health, Berlin Institute of Health and Charité Universitätsmedizin Berlin, Berlin, Germany.
Nat Cancer ; 2(1): 114-128, 2021 01.
Article em En | MEDLINE | ID: mdl-35121888

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article